Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API


SAIC Announces Second Quarter of Fiscal Year 2021 Results


Business Wire | Sep 2, 2020 04:10PM EDT

SAIC Announces Second Quarter of Fiscal Year 2021 Results

Sep. 02, 2020

RESTON, Va.--(BUSINESS WIRE)--Sep. 02, 2020--Science Applications International Corporation (NYSE: SAIC), a premier Fortune 500(r) technology integrator driving our nation's digital transformation across the defense, space, civilian, and intelligence markets, today announced results for the second quarter ended July 31, 2020.

"SAIC continues to deliver a resilient and stable revenue base, improved profitability, strong cash generation, and the highest book-to-bill and backlog in our seven-year history," said SAIC CEO Nazzic Keene. "Despite pandemic-related challenges, which we are effectively navigating, we have kept our focus on the execution of our long-term strategy, advanced our positions in key markets, and delivered strong program performance. We continue to gain strategic momentum while delivering results and value for our customers, employees, and shareholders."

Second Quarter of Fiscal Year 2021: Summary Operating Results

Three Months Ended Six Months Ended

July 31, Percent August 2, July 31, Percent August 2, 2020 change 2019 2020 change 2019

(in millions, except per share amounts)

Revenues $ 1,764 11 % $ 1,594 $ 3,521 10 % $ 3,209

Operating 100 5 % 95 178 (5) % 188 income

Operatingincome as a 5.7 % -30 bps 6.0 % 5.1 % -80 bps 5.9 %percentageof revenues

Adjustedoperating 115 14 % 101 221 9 % 202 income^(1)

Adjustedoperatingincome as a 6.5 % 20 bps 6.3 % 6.3 % - bps 6.3 %percentageof revenues

Net incomeattributable 51 (11) % 57 87 (22) % 112 to commonstockholders

EBITDA^(1) 152 19 % 128 261 2 % 255

EBITDA as apercentage 8.6 % 60 bps 8.0 % 7.4 % -50 bps 7.9 %of revenues

Adjusted 167 25 % 134 304 13 % 269 EBITDA^(1)

AdjustedEBITDA as a 9.5 % 110 bps 8.4 % 8.6 % 20 bps 8.4 %percentageof revenues

Dilutedearnings per $ 0.87 (9) % $ 0.96 $ 1.49 (21) % $ 1.88 share

Adjusteddiluted $ 1.63 21 % $ 1.35 $ 2.99 10 % $ 2.71 earnings pershare^(1)

Net cashprovided by $ 104 9 % $ 95 $ 471 73 % $ 273 operatingactivities

Free cash $ 90 - % $ 90 $ 448 73 % $ 259 flow^(1)

(1)Non-GAAP measure, see Schedule 5 for information about this measure.

COVID-19: Second Quarter Impact

We estimate the second quarter impact from the COVID-19 pandemic to be approximately $65 million of revenue, $8 million of adjusted EBITDA(1), and an immaterial net impact to free cash flow(1). These impacts were primarily driven by reduced volume in our supply chain business, lower FAA training service revenues, and uncertain profit recovery on ready-state labor. Since the onset of the COVID-19 pandemic, SAIC has operated as an essential business, continuing to operate in a resilient market and business model.

Summary Results

Revenues for the quarter increased $170 million, or 10.7%, compared to the prior year quarter due to the acquisition of Unisys Federal, revenue on new contracts primarily supporting the intelligence community and U.S. Air Force, and increased volume on existing programs, partially offset by the impacts of COVID-19 and completion of contracts. Adjusting for the impact of acquired revenues, revenues contracted 0.7% primarily due to the impacts of COVID-19.

Operating income as a percentage of revenues of 5.7%, decreased from 6.0% in the comparable prior year period due to increased intangible asset amortization and the impacts of COVID-19, partially offset by gains related to the resolution of certain legal and other program contract matters and lower indirect costs.

Net income attributable to common stockholders for the quarter decreased $6 million as compared to the same period in the prior year primarily due to higher interest expense, partially offset by increased operating income ($4 million, net of tax).

Adjusted EBITDA(1) as a percentage of revenues for the quarter increased to 9.5% of revenues from 8.4% of revenues in in the prior year quarter driven by gains related to the resolution of certain legal and program contract matters and lower indirect costs across the portfolio, partially offset by the impacts of COVID-19.

Diluted earnings per share for the quarter was $0.87 compared to $0.96 in the prior year quarter. Adjusted diluted earnings per share(1) for the quarter was $1.63 compared to $1.35 in the prior year quarter. The weighted-average diluted shares outstanding during the quarter decreased to 58.6 million from 59.1 million during the prior year quarter, primarily due to shares directly repurchased from a private equity holder in the second quarter of fiscal year 2020, as well as plan share repurchases in fiscal year 2020.

Cash Generation and Capital Deployment

Cash flows provided by operating activities for the second quarter were $104 million, an increase of $9 million compared to the same period in the prior year. The improvement is primarily due to cash provided from operating activities of Unisys Federal and deferred payroll tax payments as provided for in the CARES Act, offset by unbilled receivables related to ready-state labor, also provided for under the CARES Act.

During the quarter, SAIC deployed $163 million of capital, consisting of $21 million in cash dividends, $17 million of mandatory debt repayment, and $125 million of voluntary debt repayment. There were no share repurchases in the second quarter. Subsequent to the end of the quarter, SAIC has made voluntary debt repayment of $100 million and is confident in the de-levering plan it has previously communicated.

Quarterly Dividend Declared

Subsequent to the end of the quarter, the Company's Board of Directors declared a cash dividend of $0.37 per share of the Company's common stock payable on October 30, 2020 to stockholders of record on October 16, 2020. SAIC intends to continue paying dividends on a quarterly basis, although the declaration of any future dividends will be determined by the Board of Directors each quarter and will depend on earnings, financial condition, capital requirements and other factors.

(1)Non-GAAP measure, see Schedule 5 for information about this measure.

Backlog and Contract Awards

Net bookings for the quarter were approximately $4.6 billion, which reflects a book-to-bill ratio of 2.6. On a year-to-date basis, SAIC has produced a book to bill of 1.8. SAIC's estimated backlog of signed business orders at the end of the quarter was approximately $19.4 billion. Of the total backlog amount, approximately $3.1 billion was funded.

SAIC was awarded the following contracts during the quarter:

The U.S. Intelligence Community: SAIC was awarded more than $286 million in contracts to support various U.S. Department of Defense, space, and intelligence community customers.

Notable New Business Awards:

U.S. Air Force Advanced Battle Management System: SAIC was awarded a $950 million multiple-award indefinite-delivery, indefinite-quantity (IDIQ) contract for the maturation, demonstration, and proliferation of capability across platforms and domains, leveraging open systems design, modern software, and algorithm development in order to enable Joint All Domain Command and Control (JADC2).

U.S. Air Force Technology Application Development and Sustainment (TADS): SAIC's acquisition of Unisys Federal resulted in a six-year, $630 million single-award, IDIQ contract to support the Air Force to maintain its weather information system. Under the contract, SAIC will support an integrated system of weather enterprise hardware and software dedicated to providing accurate, consistent, relevant, and timely environmental intelligence.

U.S. Department of Agriculture (USDA) Information Technology Support Services: SAIC was awarded a position on the USDA's Information Technology Support Services (DAITSS) blanket purchase agreement (BPA) to compete for task orders worth up to $450 million, for all awardees. Under the BPA, SAIC will compete to provide a broad range of enterprise IT support services including artificial intelligence, robotic process automation, machine learning, and other innovative and emerging technologies across all of the department's agencies and offices.

U.S. Air Force Engineering Services for the 414th Supply Chain Management Squadron: SAIC will deliver mission engineering services to the U.S. Air Force 414th Supply Chain Management Squadron's Intercontinental Ballistic Missile LGM-30 Minuteman III missile system under a $79 million, five-year task order, awarded as part of the Information Analysis Center Multiple Award Contract (IAC-MAC).

Notable Recompete Awards:

U.S. Army Aviation and Missile Command (AMCOM) Software Life Cycle Development: SAIC was awarded a $2.9 billion contract to continue mission engineering, integration, software development, and other life cycle support to AMCOM. Under the potential five-year task order, SAIC will continue to develop and integrate advanced technologies throughout the software life cycle, including software development and maintenance.

U.S. Navy Fleet Deployment Training Program SAIC was awarded a $171 million contract to continue providing a range of training solutions, including virtual and synthetic training environments, as part of the Fleet Deployment Training Program supporting the Navy Fleet Forces and associated fleet commands and activities. The contract has a ten-month base period of performance, four one-year options, and one six-month option extension.

U.S. Navy Intelligence, Surveillance, and Reconnaissance Engineering and Technical Services SAIC was awarded a $133 million contract to continue providing mission engineering and integration services to the Maneuver, Engagement, and Surveillance Systems Division at Naval Surface Warfare Center in Crane, Indiana. Under the contract, which has a one-year base period of performance and four one-year options, SAIC will deliver engineering, technical support, analysis and modeling, studies, inventory and logistics, and quality assurance services in support of tactical intelligence, surveillance, and reconnaissance systems.

U.S. Navy Advanced Hypersonic Technologies Support SAIC was awarded a $64 million task order under the SeaPort-NxG IDIQ contract to provide mission engineering and integration services to the Naval Surface Warfare Center in Crane, Indiana. Under the task order, SAIC will deliver expertise, facilities, equipment, and administration support for advanced hypersonic technologies. The task order has a one-year base period of performance and four one-year options.

Other Second Quarter News

SAIC Announces New Innovation Factory in Huntsville, Alabama SAIC announced plans to add a new Innovation Factory Hub in Huntsville, Alabama, the Company's second largest location, expanding its presence and support to local customers. This marks the latest expansion of SAIC's Innovation Factory network where the Department of Defense and other federal government agencies can evaluate new technologies and accelerate delivery of new and modernized systems.

SAIC Donation Supports Save Space Camp Campaign SAIC recently donated $250,000 to the U.S. Space and Rocket Center's Save Space Camp campaign. Due to the COVID-19 pandemic, the center experienced a dramatic reduction in attendance at the U.S. Space and Rocket Center museum and Space Camp in Huntsville, Alabama, leading to a significant decrease in revenue and operating capital. With SAIC's donation, the organization exceeded its goal of raising $1.5 million to sustain museum operations and to be able to reopen Space Camp in April 2021.

Fiscal Year 2021 Guidance

As a result of the Company's year-to-date performance and future expectations, to include expected impacts from the COVID-19 pandemic, the Company is updating previously provided fiscal year 2021 guidance. The updated guidance assumes the potential impact of the COVID-19 pandemic to be $250 million in revenue and $35 million in adjusted EBITDA, an increase from previous estimates. The provided guidance also assumes continued impact from COVID-19 through the end of fiscal year 2021 (January 29, 2021) and that support currently provided under Section 3610 of the CARES Act is extended through that period. The table below summarizes fiscal year 2021 guidance and represents our views as of September 2, 2020.

Current Fiscal Year Prior Fiscal Year

2021 Guidance 2021 Guidance

Revenue $7.1 billion - $7.2 $7.1 billion - $7.3 billion billion

Adjusted Diluted EPS^(1) $5.80 - $6.10 $5.80 - $6.10

Free Cash Flow^(1) meet or exceed $500 meet or exceed $500 million million

(1)Non-GAAP measure, see Schedule 5 for information about this measure.

Webcast Information

SAIC management will discuss operations and financial results in an earnings conference call beginning at 5:00 p.m. Eastern time on September 2, 2020. The conference call will be webcast simultaneously to the public through a link on the Investor Relations section of the SAIC website ( http://investors.saic.com). We will be providing webcast access only - "dial-in" access is no longer available. Additionally, a supplemental presentation will be available to the public through links to the Investor Relations section of the SAIC website. After the call concludes, an on-demand audio replay of the webcast can be accessed on the Investor Relations website.

About SAIC

SAIC(r) is a premier Fortune 500(r) technology integrator driving our nation's digital transformation. Our robust portfolio of offerings across the defense, space, civilian, and intelligence markets includes secure high-end solutions in engineering, IT modernization, and mission solutions. Using our expertise and understanding of existing and emerging technologies, we integrate the best components from our own portfolio and our partner ecosystem to deliver innovative, effective, and efficient solutions that are critical to achieving our customers' missions.

We are 25,500 strong; driven by mission, united by purpose, and inspired by opportunities. Headquartered in Reston, Virginia, SAIC has pro forma annual revenues of approximately $7.1 billion. For more information, visit saic.com. For ongoing news, please visit our newsroom.

Forward-Looking Statements

Certain statements in this release contain or are based on "forward-looking" information within the meaning of the Private Securities Litigation Reform Act of 1995. In some cases, you can identify forward-looking statements by words such as "expects," "intends," "plans," "anticipates," "believes," "estimates," "guidance," and similar words or phrases. Forward-looking statements in this release may include, among others, estimates of future revenues, operating income, earnings, earnings per share, charges, total contract value, backlog, outstanding shares and cash flows, as well as statements about future dividends, share repurchases and other capital deployment plans. Such statements are not guarantees of future performance and involve risk, uncertainties and assumptions, and actual results may differ materially from the guidance and other forward-looking statements made in this release as a result of various factors. Risks, uncertainties and assumptions that could cause or contribute to these material differences include those discussed in the "Risk Factors," "Management's Discussion and Analysis of Financial Condition and Results of Operations" and "Legal Proceedings" sections of our Annual Report on Form 10-K, as updated in any subsequent Quarterly Reports on Form 10-Q and other filings with the SEC, which may be viewed or obtained through the Investor Relations section of our website at www.saic.com or on the SEC's website at www.sec.gov. Due to such risks, uncertainties and assumptions you are cautioned not to place undue reliance on such forward-looking statements, which speak only as of the date hereof. SAIC expressly disclaims any duty to update any forward-looking statement provided in this release to reflect subsequent events, actual results or changes in SAIC's expectations. SAIC also disclaims any duty to comment upon or correct information that may be contained in reports published by investment analysts or others.

Schedule 1

SCIENCE APPLICATIONS INTERNATIONAL CORPORATION

CONDENSED AND CONSOLIDATED STATEMENTS OF INCOME

(Unaudited)

Three Months Ended Six Months Ended

July 31, August 2, July 31, August 2, 2020 2019 2020 2019

(in millions, except per share amounts)

Revenues $ 1,764 $ 1,594 $ 3,521 $ 3,209

Cost of revenues 1,564 1,409 3,138 2,844

Selling, general and 89 82 165 159 administrative expenses

Acquisition and integration 15 8 44 18 costs

Other operating income (4) - (4) -

Operating income 100 95 178 188

Interest expense 32 22 63 47

Other (income) expense, net (2) (1) - (3)

Income before income taxes 70 74 115 144

Provision for income taxes (17) (17) (25) (31)

Net income $ 53 $ 57 $ 90 $ 113

Net income attributable to 2 - 3 1 non-controlling interest

Net income attributable to $ 51 $ 57 $ 87 $ 112 common stockholders

Weighted-average number of shares outstanding:

Basic 58.1 58.6 58.0 59.0

Diluted 58.6 59.1 58.5 59.6

Earnings per share:

Basic $ 0.88 $ 0.97 $ 1.50 $ 1.90

Diluted $ 0.87 $ 0.96 $ 1.49 $ 1.88

Schedule 2:

SCIENCE APPLICATIONS INTERNATIONAL CORPORATION

CONDENSED AND CONSOLIDATED BALANCE SHEETS

(Unaudited)

July 31, January 31, 2020 2020

(in millions)

ASSETS

Current assets:

Cash and cash equivalents $ 197 $ 188

Receivables, net 1,032 1,099

Inventory, prepaid expenses and other current 184 143 assets

Total current assets 1,413 1,430

Goodwill 2,789 2,139

Intangible assets, net 1,217 711

Property, plant, and equipment, net 103 91

Operating lease right of use assets 251 190

Other assets 174 150

Total assets $ 5,947 $ 4,711

LIABILITIES AND EQUITY

Current liabilities:

Accounts payable and accrued liabilities $ 952 $ 814

Accrued payroll and employee benefits 331 244

Long-term debt, current portion 90 70

Total current liabilities 1,373 1,128

Long-term debt, net of current portion 2,657 1,851

Operating lease liabilities 223 172

Other long-term liabilities 244 133

Total common stockholders' equity 1,437 1,417

Non-controlling interest 13 10

Total stockholders' equity 1,450 1,427

Total liabilities and stockholders' equity $ 5,947 $ 4,711

Schedule 3:

SCIENCE APPLICATIONS INTERNATIONAL CORPORATION

CONDENSED AND CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

Three Months Six Months Ended Ended

July August July 31, August 31, 2, 2019 2020 2, 2019 2020

(in millions)

Cash flows from operating activities:

Net income $ 53 $ 57 $ 90 $ 113

Adjustments to reconcile net income tonet cash provided by operating activities:

Depreciation and amortization 50 33 83 66

Amortization of off-market customer (7) - (7) - contracts

Amortization of debt issuance costs 6 1 12 4

Deferred income taxes 1 7 11 16

Stock-based compensation expense 10 12 19 20

Loss on divestiture 10 - 10 -

Increase (decrease) resulting fromchanges in operating assets and liabilities, net of the effect of theacquisition:

Receivables 8 6 151 17

Inventory, prepaid expenses and other 6 (5) (15) 11 current assets

Other assets (5) 1 (7) (2)

Accounts payable and accrued (70) (17) (4) 7 liabilities

Accrued payroll and employee benefits (3) - 80 18

Operating lease assets and liabilities, (3) 1 (5) - net

Other long-term liabilities 48 (1) 53 3

Net cash provided by operating 104 95 471 273 activities

Cash flows from investing activities:

Expenditures for property, plant, and (14) (5) (23) (14) equipment

Purchases of marketable securities (1) (1) (4) (22)

Sales of marketable securities 1 2 7 2

Cash paid for acquisition (6) - (1,202) -

Proceeds from divestiture 1 - 1 -

Other (2) (3) (2) (3)

Net cash used in investing activities (21) (7) (1,223) (37)

Cash flows from financing activities:

Dividend payments to stockholders (21) (21) (44) (44)

Principal payments on borrowings (142) (2) (158) (155)

Issuances of stock 3 3 6 5

Stock repurchased and retired or - (139) (12) (195) withheld for taxes on equity awards

Proceeds from borrowings - 100 1,000 100

Debt issuance costs - - (27) -

Distributions to non-controlling (2) (1) - (5) interest

Net cash (used in) provided by (162) (60) 765 (294) financing activities

Net (decrease) increase in cash, cash (79) 28 13 (58) equivalents and restricted cash

Cash, cash equivalents and restricted 294 160 202 246 cash at beginning of period

Cash, cash equivalents and restricted $ 215 $ 188 $ 215 $ 188 cash at end of period

Schedule 4:

SCIENCE APPLICATIONS INTERNATIONAL CORPORATION

BACKLOG

(Unaudited)

The estimated value of our total backlogas of the dates presented was:

July 31, May 1, January 31, 2020 2020 2020

(in millions)

Funded backlog $ 3,144 $ 3,329 $ 2,569

Negotiated unfunded backlog 16,280 13,304 12,748

Total backlog $ 19,424 $ 16,633 $ 15,317

Backlog represents the estimated amount of future revenues to be recognized under negotiated contracts and task orders as work is performed and excludes contract awards which have been protested by competitors until the protest is resolved in our favor. SAIC segregates backlog into two categories, funded backlog and negotiated unfunded backlog. Funded backlog for contracts with government agencies primarily represents contracts for which funding is appropriated less revenues previously recognized on these contracts, and does not include the unfunded portion of contracts where funding is incrementally appropriated or authorized by the U.S. government and other customers even though the contract may call for performance over a number of years. Funded backlog for contracts with non-government agencies represents the estimated value of contracts which may cover multiple future years under which SAIC is obligated to perform, less revenues previously recognized on these contracts. Negotiated unfunded backlog represents the estimated future revenues to be earned from negotiated contracts for which funding has not been appropriated or authorized, and unexercised priced contract options. Negotiated unfunded backlog does not include any estimate of future potential task orders expected to be awarded under indefinite-delivery, indefinite-quantity (IDIQ), U.S. General Services Administration (GSA) schedules or other master agreement contract vehicles.

Schedule 5:

SCIENCE APPLICATIONS INTERNATIONAL CORPORATION

NON-GAAP FINANCIAL MEASURES

(Unaudited)

This schedule describes the non-GAAP financial measures included in this earnings release. While we believe that these non-GAAP financial measures may be useful in evaluating our financial information, they should be considered as supplemental in nature and not as a substitute for financial information prepared in accordance with GAAP. Reconciliations, definitions, and how we believe these measures are useful to management and investors are provided below. Other companies may define similar measures differently.

EBITDA, Adjusted EBITDA and Adjusted Operating Income

Three Months Ended Six Months Ended

July 31, August 2, July 31, August 2, 2020 2019 2020 2019

(in millions)

Net income $ 53 $ 57 $ 90 $ 113

Interest expense and loss on sale 32 22 64 47 of receivables

Interest income - (1) (1) (2)

Provision for income taxes 17 17 25 31

Depreciation and amortization 50 33 83 66

EBITDA^(1) 152 128 261 255

EBITDA as a percentage of revenues 8.6 % 8.0 % 7.4 % 7.9 %

Acquisition and integration costs 15 8 44 18

Recovery of acquisition and - (2) (1) (4) integration costs

Adjusted EBITDA^(1) $ 167 $ 134 $ 304 $ 269

Adjusted EBITDA as a percentage of 9.5 % 8.4 % 8.6 % 8.4 %revenues

Operating income $ 100 $ 95 $ 178 $ 188

Operating income as a percentage of 5.7 % 6.0 % 5.1 % 5.9 %revenues

Acquisition and integration costs 15 8 44 18

Recovery of acquisition and - (2) (1) (4) integration costs

Adjusted operating income^(1) $ 115 $ 101 $ 221 $ 202

Adjusted operating income as a 6.5 % 6.3 % 6.3 % 6.3 %percentage of revenues



EBITDA is a performance measure that is calculated by taking net income and excluding interest and loss on sale of receivables, provision for income taxes, and depreciation and amortization. Adjusted EBITDA and adjusted operating income are performance measures that exclude acquisition and integration costs that we do not consider to be indicative of our ongoing operating performance. The acquisition and integration costs relate to the Company's significant acquisitions of Engility and Unisys Federal. The recovery of acquisition and integration costs relate to acquisition and integration costs recovered through the Company's indirect rates in accordance with Cost Accounting Standards. We believe that these performance measures provide management and investors with useful information in assessing trends in our ongoing operating performance and may provide greater visibility in understanding the long-term financial performance of the Company.

(1)Non-GAAP measure, see above for definition.

Schedule 5 (continued):

SCIENCE APPLICATIONS INTERNATIONAL CORPORATION

NON-GAAP FINANCIAL MEASURES

(Unaudited)

Adjusted Diluted Earnings Per Share

Three Months Ended Six Months Ended

July 31, August July 31, August 2020 2, 2019 2020 2, 2019

Diluted earnings per share $ 0.87 $ 0.96 $ 1.49 $ 1.88



Acquisition and integration costs,divided by diluted 'weighted-average 0.26 0.10 0.74 0.24 number of shares outstanding' (WASO)

Tax effect of acquisition andintegration costs, divided by diluted (0.04) (0.02) (0.14) (0.05) WASO

Net effect of acquisition andintegration costs, divided by diluted 0.22 0.08 0.60 0.19 WASO



Amortization of intangible assets, 0.72 0.41 1.16 0.82 divided by diluted WASO

Tax effect of amortization ofintangible assets, divided by diluted (0.18) (0.10) (0.26) (0.18) WASO

Net effect of amortization ofintangible assets, divided by diluted 0.54 0.31 0.90 0.64 WASO



Adjusted diluted earnings per share^ $ 1.63 $ 1.35 $ 2.99 $ 2.71 (1)

Adjusted diluted earnings per share is a performance measure that excludes acquisition and integration costs that we do not consider to be indicative of our ongoing operating performance. The acquisition and integration costs relate to the Company's recent acquisitions of Engility and Unisys Federal and is net of the recovery of acquisition and integration costs recovered through the Company's indirect rates in accordance with Cost Accounting Standards. Adjusted diluted earnings per share also excludes amortization of intangible assets because we do not have a history of significant acquisition activity, we do not acquire businesses on a predictable cycle, and the amount of an acquisition's purchase price allocated to intangible assets and the related amortization term are unique to each acquisition. We believe that this performance measure provides management and investors with useful information in assessing trends in our ongoing operating performance and may provide greater visibility in understanding the long-term financial performance of the Company.

(1)Non-GAAP measure, see above for definition.

Schedule 5 (continued):

SCIENCE APPLICATIONS INTERNATIONAL CORPORATION

NON-GAAP FINANCIAL MEASURES

(Unaudited)

Free Cash Flow

Three Months Six Months Ended Ended

July August July 31, August 2, 31, 2, 2019 2020 2019 2020

(in millions)

Net cash provided by operating $ 104 $ 95 $ 471 $ 273 activities

Expenditures for property, plant, (14) (5) (23) (14) and equipment

Free cash flow^(1) $ 90 $ 90 $ 448 $ 259

Cash used (provided) by MARPA - - (200) - Facility

Free cash flow excluding MARPA $ 90 $ 90 $ 248 $ 259 Facility^(1)

Free cash flow is calculated by taking cash flows provided by operating activities less expenditures for property, plant, and equipment. We believe that free cash flow provides management and investors with useful information in assessing trends in our cash flows and in comparing them to other peer companies, many of whom present a similar non-GAAP liquidity measure. Additionally, the Company provides free cash flow excluding the Master Accounts Receivable Purchasing Agreement (MARPA) for the sale of certain designated eligible U.S. government receivables. Under the MARPA, the Company can sell eligible receivables up to a maximum amount of $300 million. The Company provides free cash flow excluding MARPA to allow investors to more easily compare current period results to prior period results and to results of our peers. These measures should not be considered as a measure of residual cash flow available for discretionary purposes.

(1)Non-GAAP measure, see above for definition.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200902005839/en/

CONTACT: Investor Relations: Shane Canestra, +1.703.676.2720, shane.p.canestra@saic.com Media: Lauren Presti, +1.703.676.8982, lauren.a.presti@saic.com






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC